Weiwei Wu

2.4k total citations · 1 hit paper
31 papers, 1.5k citations indexed

About

Weiwei Wu is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Weiwei Wu has authored 31 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Immunology, 13 papers in Oncology and 6 papers in Molecular Biology. Recurrent topics in Weiwei Wu's work include CAR-T cell therapy research (7 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Erythrocyte Function and Pathophysiology (4 papers). Weiwei Wu is often cited by papers focused on CAR-T cell therapy research (7 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Erythrocyte Function and Pathophysiology (4 papers). Weiwei Wu collaborates with scholars based in China, United States and Germany. Weiwei Wu's co-authors include Philipp A. Lang, Dorian B. McGavern, Abdel G. Elkahloun, Haifeng C. Xu, Stacie M. Anderson, Robin Handon, Tuoqi Wu, Yun Ji, Elizabeth Kenyon and Martha Kirby and has published in prestigious journals such as Blood, Cancer Research and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

Weiwei Wu

29 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The TCF1-Bcl6 axis counteracts type I interferon to repress exhaustion and maintain T cell stemness

2016 409 citations Weiwei Wu et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Weiwei Wu China	15	815	738	476	149	114	31	1.5k
Alice E. Denton United Kingdom	18	1.0k 1.3×	662 0.9×	566 1.2×	127 0.9×	121 1.1×	28	1.8k
Linda Quatrini Italy	25	1.1k 1.4×	658 0.9×	298 0.6×	98 0.7×	129 1.1×	40	1.7k
Aurélie Poli Luxembourg	17	1.7k 2.0×	673 0.9×	376 0.8×	246 1.7×	107 0.9×	27	2.3k
Alexis J. Combes United States	18	1.1k 1.4×	613 0.8×	526 1.1×	128 0.9×	103 0.9×	37	1.7k
Wendy K. Nevala United States	23	810 1.0×	705 1.0×	624 1.3×	80 0.5×	168 1.5×	67	1.8k
Stefaan W. Van Gool Belgium	29	1.4k 1.7×	904 1.2×	643 1.4×	125 0.8×	204 1.8×	59	2.7k
Lene Vimeux France	15	998 1.2×	749 1.0×	359 0.8×	109 0.7×	106 0.9×	21	1.5k
Marianne Strazza United States	18	434 0.5×	387 0.5×	397 0.8×	104 0.7×	72 0.6×	39	1.3k
Lung-Ji Chang United States	23	517 0.6×	427 0.6×	722 1.5×	100 0.7×	92 0.8×	35	1.6k
Nuno L. Alves Portugal	21	1.4k 1.7×	528 0.7×	463 1.0×	164 1.1×	55 0.5×	46	2.0k

Countries citing papers authored by Weiwei Wu

Since Specialization

Citations

This map shows the geographic impact of Weiwei Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiwei Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiwei Wu more than expected).

Fields of papers citing papers by Weiwei Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiwei Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiwei Wu. The network helps show where Weiwei Wu may publish in the future.

Co-authorship network of co-authors of Weiwei Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Weiwei Wu. A scholar is included among the top collaborators of Weiwei Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiwei Wu. Weiwei Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cao, Lei, Haiqing Ni, Bing Wu, et al.. (2025). A Novel Anti-CD47 Antibody TJH2201: Efficacious Tumor Suppression with Reduced RBC Toxicity via a SIRPα-Independent Mechanism. Molecular Cancer Therapeutics. 25(1). 21–33.

Dong, Qi, et al.. (2025). Mechanistic insights into granulocyte-macrophage colony-stimulating factor in combating fungal infections: Diverse fungal pathogens. Medical Mycology. 63(5).

Zhang, Zhenqing, Weiwei Wu, Xiaobin Ye, et al.. (2024). Dynamics of symptom network in patients with first-episode schizophrenia: Insight from the CNFEST project. Asian Journal of Psychiatry. 101. 104202–104202. 2 indexed citations

Olia, Adam S., Madhu Prabhakaran, Darcy R. Harris, et al.. (2024). Anti-idiotype isolation of a broad and potent influenza A virus-neutralizing human antibody. Frontiers in Immunology. 15. 1399960–1399960. 2 indexed citations

Ni, Haiqing, Mengjia Zhu, Zhihui Kuang, et al.. (2022). IBI379, a novel B cell maturation antigen/CD3 bispecific T-cell engager, displays high antitumor efficacy in preclinical models of multiple myeloma. Cancer Letters. 536. 215663–215663. 2 indexed citations

Kuang, Zhihui, Min Wu, Zhihai Wu, et al.. (2020). A Novel Bispecific Antibody with PD-L1–assisted OX40 Activation for Cancer Treatment. Molecular Cancer Therapeutics. 19(12). 2564–2574. 16 indexed citations

Wang, Yan, Haiqing Ni, Shuaixiang Zhou, et al.. (2020). Tumor-selective blockade of CD47 signaling with a CD47/PD-L1 bispecific antibody for enhanced anti-tumor activity and limited toxicity. Cancer Immunology Immunotherapy. 70(2). 365–376. 87 indexed citations

Li, Li, Zhihai Wu, Min Wu, et al.. (2020). IBI112, a selective anti-IL23p19 monoclonal antibody, displays high efficacy in IL-23-induced psoriasiform dermatitis. International Immunopharmacology. 89(Pt B). 107008–107008. 9 indexed citations

Tang, Chunli, Qing Li, Xiaoyan Deng, et al.. (2020). Discovery of lixisenatide analogues as long-acting hypoglycemic agents using novel peptide half-life extension technology based on mycophenolic acid. RSC Advances. 10(20). 12089–12104. 6 indexed citations

10.

Xu, Pei, et al.. (2019). Epithelioid inflammatory myofibroblastic sarcoma of stomach: diagnostic pitfalls and clinical characteristics.. PubMed. 12(5). 1738–1744. 14 indexed citations

11.

Wang, Jie, Jing Hua, Zhihai Wu, et al.. (2019). Durable blockade of PD-1 signaling links preclinical efficacy of sintilimab to its clinical benefit. mAbs. 11(8). 1443–1451. 97 indexed citations

12.

Wang, Xiaowen, Ruijun Zhang, Weiwei Wu, et al.. (2017). Impaired Specific Antifungal Immunity in CARD9-Deficient Patients with Phaeohyphomycosis. Journal of Investigative Dermatology. 138(3). 607–617. 58 indexed citations

13.

Liu, Chaoqian, Yan Guo, Weiwei Wu, et al.. (2017). Plasma olfactomedin 4 level in peripheral blood and its association with clinical features of breast cancer. Oncology Letters. 14(6). 8106–8113. 2 indexed citations

14.

Wu, Weiwei, Ruijun Zhang, Xiaowen Wang, et al.. (2016). Impairment of Immune Response against Dematiaceous Fungi in Card9 Knockout Mice. Mycopathologia. 181(9-10). 631–642. 22 indexed citations

15.

Kong, Bo, Tao Cheng, Weiwei Wu, et al.. (2015). Pancreas-specific activation of mTOR and loss of p53 induce tumors reminiscent of acinar cell carcinoma. Molecular Cancer. 14(1). 212–212. 8 indexed citations

16.

Wu, Weiwei, Shuangbo Kong, Bingyan Wang, Yongjie Chen, & Haibin Wang. (2015). Spatiotemporal expression of endogenous opioid processing enzymes in mouse uterus at peri-implantation. Cell and Tissue Research. 363(2). 555–565. 1 indexed citations

17.

Kong, Bo, Tao Cheng, Weiwei Wu, et al.. (2015). Hypoxia-induced endoplasmic reticulum stress characterizes a necrotic phenotype of pancreatic cancer. Oncotarget. 6(31). 32154–32160. 33 indexed citations

18.

Fu, Zheng, Yongjie Chen, Weiwei Wu, et al.. (2013). Molecular and cellular aspects of blastocyst dormancy and reactivation for implantation.. PubMed. 8(2). 59–77. 3 indexed citations

19.

Lu, Shaojia, Hongjun Peng, Lifeng Wang, et al.. (2013). Elevated specific peripheral cytokines found in major depressive disorder patients with childhood trauma exposure: A cytokine antibody array analysis. Comprehensive Psychiatry. 54(7). 953–961. 82 indexed citations

20.

Chen, Bin, Weiwei Wu, & Xiaohui Wang. (2011). Magnetic Iron Oxide Nanoparticles for Tumor-Targeted Therapy. Current Cancer Drug Targets. 11(2). 184–189. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact